PharmaCielo Ltd (PCLOF)
0.15
+0.01
(+9.09%)
USD |
OTCM |
Sep 27, 12:08
PharmaCielo Debt to Equity Ratio: -3.712 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.712 |
| March 31, 2024 | -5.703 |
| December 31, 2023 | -10.88 |
| September 30, 2023 | 5.993 |
| June 30, 2023 | 4.272 |
| March 31, 2023 | 3.205 |
| December 31, 2022 | 1.921 |
| September 30, 2022 | 1.227 |
| June 30, 2022 | 0.6745 |
| March 31, 2022 | 0.4183 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.3735 |
| September 30, 2021 | 0.125 |
| June 30, 2021 | 0.0951 |
| March 31, 2021 | 0.1457 |
| December 31, 2020 | 0.1201 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-10.88
Minimum
Dec 2023
5.993
Maximum
Sep 2023
-0.086
Average
0.1225
Median
Debt to Equity Ratio Benchmarks
| Rimrock Gold Corp | -- |
| CeCors Inc | -- |
| InMed Pharmaceuticals Inc | 0.00 |
| Venus Concept Inc | 12.42 |
| Juva Life Inc | 0.9671 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.99M |
| Total Liabilities (Quarterly) | 18.95M |
| Shareholders Equity (Quarterly) | -3.961M |
| Current Ratio | 0.1378 |
| Net Debt Paydown Yield | -4.56% |